Healthlinx Inks Distribution Deal to Offer Ovarian Cancer Diagnostic Test in India
May 15, 2012
Healthlinx Inks Distribution Deal to Offer Ovarian Cancer Diagnostic Test in India
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- HealthLinx Signs South Korean Distribution Deal
December 2, 2010 / GenomeWeb Daily News - Mane Cancer Dx Requests Extension of Deadlines Related to Healthlinx OvPlex Deal
December 7, 2012 / ProteoMonitor - UPDATE: Vermillion Repays Quest $5.9M, Ending Companies' Credit Agreement
October 19, 2012 / ProteoMonitor - Healthlinx Shareholders Approve Sale of OvPlex Dx to Mane Cancer Diagnostics
October 5, 2012 / ProteoMonitor - HealthLinx Says New OvPlex Algorithm Beats CA125 in Avoiding False Positives
July 6, 2012 / ProteoMonitor